Posted: July 7, 2010

Agilent Selects SeqWright as First Target Enrichment Certified Service Provider for AB SOLiD Sequencing

(Nanowerk News) Agilent Technologies Inc. and SeqWright DNA Technology Services today announced that SeqWright is the first Certified Service Provider (CSP) for the Agilent SureSelect Target Enrichment System for use with the next-generation AB SOLiD sequencing platform.
SureSelect, a research-use-only system, has been shown to greatly increase the speed and cost-efficiency of next-generation sequencing by enabling researchers to focus experiments on genomic regions of interest rather than sequencing the entire genome. The system offers optimized protocols for the Illumina Genome Analyzer and Life Technologies' AB SOLiD platforms.
"When leading genomics companies like SeqWright add SureSelect to their extensive portfolios of services, it illustrates the momentum this technology has gained in just the year and a half since its introduction," said Fred P. Ernani, Ph.D., Agilent SureSelect platform business manager. "We are very pleased to see SeqWright gain the status of the first CSP for SureSelect on the SOLiD platform."
"All of us at SeqWright are very excited to have achieved CSP status for the SureSelect system," said Fei Lu, M.D., CEO of SeqWright. "The coupling of SureSelect with our established SOLiD pipeline provides us with an unprecedented level of flexibility to address the many needs of our next-gen sequencing customers."
About SeqWright
Houston, TX based SeqWright Incorporated is recognized as an international leader in the field of contract genomic services including multiple next-gen sequencing platforms. With more than fifteen years of experience, SeqWright specializes in state-of-the-art Molecular Biology and Genomic services, encompassing small projects to full clinical trials and all within a regulatory compliant GLP/CLIA environment. SeqWright was recently awarded a license by the state of California to operate as a clinical laboratory. This license, along with CLIA certification, allows SeqWright to handle clinical samples from a vast majority of the United States. For additional information about SeqWright and its services, please visit
Source: Agilent Technologies (press release)
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: